Featured series 
Tag: Medicine
-
Nation & World
Innovative HBS ‘immersion’ programs flourish
One of the most enduring questions in school is not about the timeless concerns, like the origin of the universe. It’s about passing time: What did you do on your vacation? That simple (and fraught) question applies even to Harvard Business School (HBS), which for nearly a hundred years has been peopled by future captains…
-
Nation & World
Terror war could strain veterans’ health, benefit systems
The cost of caring for veterans of the war on terror could reach $662 billion over the next 40 years, while demand from returning soldiers is already clogging the two major veterans’ assistance programs, according to recent research by Linda J. Bilmes, a lecturer in public policy from Harvard’s John F. Kennedy School of Government.
-
Nation & World
Ten physicians awarded grants to focus on patient safety
Ten physicians from a cross-section of Harvard teaching hospitals have been awarded a total of $500,000 in grants by CRICO/RMF – the patient safety and medical malpractice insurance company owned by and serving the Harvard-affiliated medical community.
-
Nation & World
Sengupta wins $4.1 million ‘Era of Hope’ award for breast cancer advances
An assistant professor of medicine at Harvard has won a $4.1 million “Era of Hope” scholar award from the U.S. Defense Department’s Breast Cancer Research Program in support of his cutting-edge, interdisciplinary research aimed at fighting breast and other types of cancer.
-
Nation & World
Making medical and family ends meet
For Harvard Medical School researchers and clinicians, nothing is in shorter supply than time – and time is money. For Sonya Shin, relief comes from the Eleanor and Miles Shore Fellowship for Scholars in Medicine.
-
Nation & World
HMS offers fellowships, grants
Each year, numerous postdoctoral and faculty fellowships/grants are available to the Harvard medical community by invitation only. These include the Burroughs Wellcome Career Award at the Scientific Interface, the Damon…
-
Nation & World
New myeloma drug proves more potent, less toxic than thalidomide
A designer drug significantly less toxic than thalidomide has shown impressive activity in prolonging survival of patients with advanced multiple myeloma, report researchers from Dana-Farber Cancer Institute. A multicenter Phase II study of lenalidomide, an altered version of thalidomide, found a response rate of 25 percent among patients with myeloma that had recurred despite multiple…
-
Nation & World
Prostate treatment has risks
A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology. “Men with prostate cancer have high five-year survival rates, but they also have higher rates of noncancer mortality than healthy men,” says study author…
-
Nation & World
Jim Kim, former HIV director at WHO, to head HSPH center
Jim Yong Kim, a former director of the World Health Organization’s HIV/AIDS unit, has been appointed director of the François-Xavier Bagnoud (FXB) Center for Health and Human Rights at the Harvard School of Public Health (HSPH). He will become François-Xavier Bagnoud Professor of Health and Human Rights at the School.
-
Nation & World
Heat waves deadliest for blacks, diabetics
Heat waves, like the one that scorched the country in July, are more deadly for some people than for others. Poor blacks and diabetics fare the worst. As you might guess, extreme heat is also hard on the elderly. But as you might not guess, extreme cold has a greater impact.